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Rapid Hemodynamic Deterioration and Death due to 
Acute Severe Refractory Septic Shock
Abhijeet Dhoblea, b, Won Chunga
Abstract
          Despite emergence of early goal directed therapy, septic shock 
still carries a high mortality. Gram negative septicemia is notorious 
for rapid deterioration due to endotoxin release. Multi-organ dam-
age due to septic shock carries poor prognosis, and such patients 
should be managed aggressively with multidisciplinary approach. 
We present a fatal case of a patient with gram negative septicemia 
who rapidly deteriorated, and died due to acute refractory severe 
septic shock. This patient probably developed urosepsis secondary 
to severe urinary tract infection. He also had infiltrates on chest ra-
diograph. He expired within fifteen hours of presenting to the emer-
gency department. This case emphasizes the importance of early 
recognition and management of septic shock. Early goal directed 
therapy has shown to improve mortality. Broad spectrum antibiot-
ics should be started within one hour depending on local immunity 
of organisms. This case also highlights the fact that despite opti-
mized treatment, this entity has very high mortality rates.
Keywords:  Hemodynamic deterioration; Refractory septic shock; 
Gram negative septicemia
Introduction
   Sepsis is a clinical syndrome which is characterized by 
severe infection leading to systemic inflammation and wide-
spread cellular injury [1]. Similar systemic response also oc-
curs in the absence of an infection. This entity is different 
from culture negative sepsis syndrome, in which case there 
is an evidence or suspicion of infection, but blood or body 
fluid cultures are negative [2,3]. In fact, blood cultures are 
negative in 30 to 80 percent of patients with sepsis depend-
ing on the severity of syndrome [3]. 
 Bloodstream infection is associated with high mortal-
ity rates. When bacteremia is associated with severe septic 
shock, gram negative and gram positive bacteria have com-
parable outcomes [4]. Dysregulation of anti and pro-inflam-
matory modulators is currently believed to be the center of 
pathogenesis  of  sepsis  syndrome.  Excessive  spill  of  pro-
inflammatory cytokines results in vasodilatation, increased 
endothelial permeability, leukocyte accumulation and neu-
trophils degranulation; leading to chain of events ensuing ex-
tensive tissue injury [5]. Cellular injury also plays an impor-
tant role in the pathogenesis of sepsis through local hypoxia, 
apoptosis of injured cells, and direct cytotoxic effects [6]. 
Combination of excessive inflammation and cellular injury 
gives rise to full blown picture of sepsis syndrome (Fig. 1).
  Gram negative septicemia is notorious for rapid dete-
rioration due to endotoxin release [7]. Multi-organ damage 
due to septic shock carries poor prognosis, and such patients 
should be managed aggressively with multidisciplinary ap-
proach [8]. In spite of optimum treatment, refractory septic 
shock has very high mortality rates up to 50% [9]. Early goal 
directed therapy (EGDT) has shown to improve short and 
long term survival in these patients by 20%. EGDT is the 
mainstay of therapy while treating these patients [10]. We 
present a not very uncommon case of acute refractory gram 
negative septic shock, which rapidly deteriorated and died 
within 15 hours of his initial presentation to the emergency 
department. 
Case Report
  A 65-years-old male patient presented to emergency 
department with complaints of progressive dyspnea, dysuria, 
and change in mental status in last six hours. The patient had 
a history of hypertension, type-2 diabetes mellitus, coronary 
artery disease, hypertriglyceridemia, peripheral vascular dis-
ease, chronic pancreatitis, gastroesophageal reflux disease, 
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chronic back pain and depression. Surgical history included 
left popliteal-femoral bypass and coronary artery stenting. 
He had 25-pack-years history of smoking, but denied sig-
nificant alcohol or illicit drug use. His customary medica-
tions were lantus insulin, glimeperide, verapamil, losartan, 
aspirin, rosuvastatin, fenofibrate, cilostazole, esomeprazole, 
dicyclomine, eszopiclone, venlafaxine, alprazolam, testos-
terone lotion, and hydrocodone-acetaminophen. 
  On physical examination, he was alert but not oriented, 
and in severe respiratory distress. Blood pressure (BP) was 
160/94 mmHg in right arm, pulse rate was 140 per minute, 
respiratory rate was 30 breaths per minute, and temperature 
was 38.4oC. The Oxygen saturation via pulse oximeter was 
86% while the patient was breathing 100% O2 by non-re-
breather mask. There was decreased air movement at both 
lung bases, and consolidation at right lung base. Cardiac ex-
amination showed no abnormalities except tachycardia. The 
remainder of the examination was unremarkable. 
  The initial labs and arterial blood gas (ABG) analysis 
are shown in table 1 and 2. Serum lactate at the beginning 
was elevated at 4.1 mmol/L (normal: 0.5-1 mmol/L). Initial 
electrocardiogram showed sinus tachycardia with rate of 144 
beats per minute. A chest radiograph showed increased in-
terstitial markings and right lower lobe infiltrates (Fig. 2). 
Urine analysis study revealed presence of urinary tract infec-
tion and results are shown in Table 3. He was immediately 
started  on  fluid  replacement,  intravenous  (IV)  antibiotics 
which  included  levofloxacin,  piperacillin/tazobactam  and 
vancomycin, and high flow oxygen, and was transferred to 
medical intensive care unit (ICU) for further care.
  Later on, patient went into severe respiratory distress, 
and endotrachial intubation was performed. Soon after intu-
bation, patient went into pulseless electrical activity, and a 
code blue was called. Cardio-pulmonary resuscitation was 
performed as per standard protocol for 15 minutes, and pa-
tient came back to sinus rhythm. After the code, patient was 
hypotensive and required three vasopressors including epi-
nephrine, norepinephrine and dopamine to maintain systolic 
BP more than 90. Oxygen saturation was 90% on 100% FiO2. 
After one hour, patient again went into cardiac asystole, then 
ventricular fibrillation, and then pulseless electrical activ-
ity. Successful resuscitation was done for 15 minutes. After 
this second code, the systolic BP was in 80s, and IV phen-
ylephrine was added. Hear rate was 146 beats per minute, 
and oxygen saturation 88% on 100% FiO2. The laboratory 
results showed lactate level of 12.1 mmol/L; transaminase 
in 1000’s and blood urea nitrogen and creatinine of 53 mg/
dl and 4.9 mg/dl respectively. Serum troponin level was 2.92 
ng/ml (normal ≤ 0.04 ng/ml). Arterial blood gas (ABG) re-
vealed worsening metabolic acidosis. 
   An  emergent  two-dimensional  echocardiogram  was 
obtained and revealed normal left and right ventricular func-
tion. His left ventricular ejection fraction was found to be 
50%, and there was no pericardial effusion, or right ven-
tricular strain. Patient was started on IV hydrocortisone, and 
anidulafungin was added to cover for fungal pathogens. A 
decision was also made to start patient on activated protein 
C infusion considering high risk of death. In addition, bicar-
bonate drip was also started. 
  Twelve hours after his admission to this hospital, patient 
started showing signs of anoxic brain injury. At that time, he 
was on maximum doses of five vasopressors, but was still hy-
potensive and tachycardic. The oxygen saturation decreased 
to 88% on 100% of FiO2. ABG at that time is shown in Table 
2. Family meeting was called, and they requested for with-
drawal of care. Thirty minutes later, care was withdrawn and 
Figure 1. Pathogenesis of sepsis.
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patient expired within 10 minutes of extubation and stopping 
IV medications. Family refused autopsy. The next day, two 
out of four blood cultures were positive for Escherichia coli. 
 
Discussion
  There are approximately 750,000 cases of sepsis di-
agnosed in the United States annually [11]. It occurs in ap-
proximately two percent of hospitalized patients and up to 
75 percent of intensive care unit patients [12-15].  Hospital 
mortality rate for sepsis patients ranges from 20 to 50 percent 
[12]. Despite an 8 percent per year increase in the incidence 
of sepsis, mortality rate have declined over the past 20 years 
[12-14]. Among patients with sepsis, the severity of disease 
appears to be increasing. In one large retrospective analysis, 
the proportion of patients with severe sepsis increased from 
26 to 44 percent over a decade [13, 14]. Despite this, hospital 
case-fatality rates declined dramatically [15]. The trends of 
increasing incidence and improved survival have also been 
observed for septic shock [12-15]. Mortality rates increase 
stepwise according to disease severity [12-14].
   The contribution of various infectious organisms to the 
burden of disease has changed over time. Gram negative ba-
cilli were the predominant organisms associated with noso-
comial bacteremia in the US prior to the 1980s [16]. Gram 
positive aerobes now outnumber Gram negative organisms 
[11, 17], especially the emergence of methicillin resistant 
staphylococcus  aureus. Although  the  percentage  of  gram 
negative bacillary bacteremia has decreased, these cause se-
rious multidrug resistance problems increasing mortality rate 
[18], and is usually associated with at least one comorbid 
condition [19]. In 2003, gram-negative bacilli were respon-
Test Value Value range
Sodium 136 meq/l 135-145
Potassium 3.6 meq/l 3.5-4.9
Chloride 112 meq/l 96-110
CO2 11 mmol/l 20-30
Blood urea 
nitrogen
28 mg/dl 6.0-23.0
Creatnine 1.7 mg/dl 0.6-1.4
Total protein 6.4 g/dl 6.0-8.0
Albumin 3.7 g/dl 3.6-5.0
Magnesium 1.4 meq/l 1.3-2.2
Phosphorus 3.2 mg/dl 2.5-4.5
Calcium 8.3 mg/dl 8.0-10.5
White blood count 13,900/mm3 4-12
Hemoglobin 13.6 g/dl 12.6-16.5
Platelet count 119,000/mm3 150-400
Table 1. Initial laboratory values
ABG
At 
presentation
After 
12 hours
Normal 
values
pH 7.26 6.9
7.35-
7.45
PaO2
(mm Hg)
68 90 80-95 
PaCO2
(mm Hg)
25 37 35-45 
HCO3
-
(mEq/L)
10.6 6 22-26 
O2 
Saturation
85% 84% 95-99%
FiO2 100% 100%
Table 2. Arterial blood gas analysis
Figure 2. Chest radiograph at presentation.
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sible for 24 percent of nosocomial bacteremias in ICUs [16]. 
  American college of chest physicians and society of 
critical care medicine have proposed definitions of sepsis 
and related syndromes (Fig. 3); and these are widely used 
while  stratifying  the  risks  for  hospitalized  patients  [20]. 
These definitions of systemic inflammatory response syn-
drome (SIRS), sepsis, severe sepsis, and septic shock are 
based on clinical experience and the correlation of infection 
progression with appropriate physiologic responses. 
  EGDT has shown to increase survival by 20% [10], and 
should be initiated as soon as the diagnosis is suspected. This 
include invasive hemodynamic monitoring with the aim of 
maintaining: central venous pressure (CVP) between 8 and 
12 mmHg, mean arterial pressure 65 mmHg, urine output 
0.5 mL/kg/hr, and central venous or mixed venous oxygen 
(SvO2) saturation 70%. If the SvO2 is less than 70% after 
maintain CVP of 8-12 mmHg, infusion of packed red blood 
cells is indicated to maintain hematocrit of at least 30%. Do-
butamine infusion is also indicated if cardiac output is com-
promised [10, 20]. Appropriate cultures should be obtained 
before starting antibiotics. 
  Intravenous antibiotics should be started as early as 
possible and always within the first hour of recognizing se-
vere sepsis and septic shock [20]. The site of infection and 
responsible microorganisms are usually not known initially 
in a patient with sepsis. Antibiotic treatment must be guided 
by the patient’s susceptibility group and local knowledge of 
bacterial resistance [21]. Intravenous broad spectrum antibi-
otics directed against both gram positive and gram negative 
bacteria should be administered immediately after appropri-
ate cultures have been obtained. Few guidelines exist for the 
initial selection of empiric antibiotics. If pseudomonas is an 
unlikely pathogen, combination of vancomycin with either 
the third or fourth generation cephalosporin, or beta-lactam/
Test Findings Normal values
White blood count >100/hpf 0-2/hpf
Red blood count 1/hpf 0-2/hpf
Bacteria many none
Leukocyte esterase  Positive (large) Negative 
Nitrite  Positive (large) Negative
Table 3. Urine analysis
Figure 3. Definitions used to describe the condition of septic patients (Adapted from American college of chest physicians 
and society of critical care medicine’s surviving sepsis campaign published in 2008).
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beta-lactamase inhibitor, or carbapenem is an excellent ini-
tial choice. If pseudomonas is a possible pathogen, combina-
tion of vancomycin and two antipseudomonal agents should 
be considered. Antifungal agent may be considered initially 
if risk factors for fungal infection are present, or within 48 
hours if no improvement occurs [21]. Antimicrobial regimen 
should be reassessed in 48-72 hours on the basis of microbi-
ological and clinical data [22]. Antibiotics should be stopped 
if the cause is found to be non-infectious.
  Intravenous hydrocortisone is indicated for adult septic 
shock when hypotension responds poorly to adequate fluid 
resuscitation and vasopressors. Hydrocortisone dose should 
be ≤ 300 mg/day. Steroids are not recommended to treat sep-
sis in the absence of shock unless the patient’s endocrine or 
corticosteroid history warrants it [23]. Recombinant human 
activated protein C should be considered in adult patients 
with sepsis-induced organ dysfunction with clinical assess-
ment of high risk of death and if there are no contraindica-
tions [24].
  Our case emphasizes the importance of early recogni-
tion and management of septic shock. Gram negative septi-
cemia is notorious for rapid deterioration due to endotoxin 
release. Multi-organ damage due to septic shock carries poor 
prognosis, and such patients should be managed aggressive-
ly with multidisciplinary approach. This case also highlights 
the fact that despite optimized treatment, this entity has very 
high mortality rates as shown in the previous studies. None-
theless, early recognition, EGDT, and initiation of intrave-
nous antibiotics are key components in treating patients with 
sepsis and septic shock.
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